1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine

C149H300F6N22O18 — CID 165031813

IUPAC1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine
SMILESCC(C)(C)NC1CCOC1.CC(C)(C)NCC1CN(C(=O)C(F)(F)F)CCO1.CC(C)(C)NCC1CN(C2COC2)CCO1.CC(C)(C)NCCC1CCCOC1.CC(C)(C)NC[C@@H]1CN(C2COC2)CCO1.CC(C)(C)NC[C@H]1CN(C(=O)C(F)(F)F)CCO1.CC(C)(C)NC[C@H]1CN(C2COC2)CCO1.CC(C)(C)N[C@@H]1CCOC1.CC(C)(C)N[C@H]1CCOC1.CCN1CCO[C@@H](CCCCC(C)(C)C)C1.CCN1CCO[C@H](CCCCC(C)(C)C)C1.CN(C)CC(=O)N1CCC(CNC(C)(C)C)CC1.CN(C)CC(=O)N1CCCC(CNC(C)(C)C)C1
InChIInChI=1S/2C14H29N3O.2C14H29NO.3C12H24N2O2.2C11H19F3N2O2.C11H23NO.3C8H17NO/c1-14(2,3)15-10-12-6-8-17(9-7-12)13(18)11-16(4)5;1-14(2,3)15-9-12-7-6-8-17(10-12)13(18)11-16(4)5;2*1-5-15-10-11-16-13(12-15)8-6-7-9-14(2,3)4;3*1-12(2,3)13-6-11-7-14(4-5-16-11)10-8-15-9-10;2*1-10(2,3)15-6-8-7-16(4-5-18-8)9(17)11(12,13)14;1-11(2,3)12-7-6-10-5-4-8-13-9-10;3*1-8(2,3)9-7-4-5-10-6-7/h2*12,15H,6-11H2,1-5H3;2*13H,5-12H2,1-4H3;3*10-11,13H,4-9H2,1-3H3;2*8,15H,4-7H2,1-3H3;10,12H,4-9H2,1-3H3;3*7,9H,4-6H2,1-3H3/t;;2*13-;2*11-;;8-;;;2*7-;/m..1010.0..10./s1
InChIKeyMTSPVILWFDDQST-HCGLHAMGSA-N
MW2802.16 g/mol
LogP18.41
Rot. Bonds37

About 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine

1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine (PubChem CID 165031813) has the molecular formula C149H300F6N22O18 and a molecular weight of 2802.16 g/mol. Its IUPAC name is 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine.

Molecular Properties

Compound Name1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine
PubChem CID165031813
Molecular FormulaC149H300F6N22O18
Molecular Weight2802.16 g/mol
Exact Mass2800.31
IUPAC Name1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine
SMILESCC(C)(C)NC1CCOC1.CC(C)(C)NCC1CN(C(=O)C(F)(F)F)CCO1.CC(C)(C)NCC1CN(C2COC2)CCO1.CC(C)(C)NCCC1CCCOC1.CC(C)(C)NC[C@@H]1CN(C2COC2)CCO1.CC(C)(C)NC[C@H]1CN(C(=O)C(F)(F)F)CCO1.CC(C)(C)NC[C@H]1CN(C2COC2)CCO1.CC(C)(C)N[C@@H]1CCOC1.CC(C)(C)N[C@H]1CCOC1.CCN1CCO[C@@H](CCCCC(C)(C)C)C1.CCN1CCO[C@H](CCCCC(C)(C)C)C1.CN(C)CC(=O)N1CCC(CNC(C)(C)C)CC1.CN(C)CC(=O)N1CCCC(CNC(C)(C)C)C1
InChIInChI=1S/2C14H29N3O.2C14H29NO.3C12H24N2O2.2C11H19F3N2O2.C11H23NO.3C8H17NO/c1-14(2,3)15-10-12-6-8-17(9-7-12)13(18)11-16(4)5;1-14(2,3)15-9-12-7-6-8-17(10-12)13(18)11-16(4)5;2*1-5-15-10-11-16-13(12-15)8-6-7-9-14(2,3)4;3*1-12(2,3)13-6-11-7-14(4-5-16-11)10-8-15-9-10;2*1-10(2,3)15-6-8-7-16(4-5-18-8)9(17)11(12,13)14;1-11(2,3)12-7-6-10-5-4-8-13-9-10;3*1-8(2,3)9-7-4-5-10-6-7/h2*12,15H,6-11H2,1-5H3;2*13H,5-12H2,1-4H3;3*10-11,13H,4-9H2,1-3H3;2*8,15H,4-7H2,1-3H3;10,12H,4-9H2,1-3H3;3*7,9H,4-6H2,1-3H3/t;;2*13-;2*11-;;8-;;;2*7-;/m..1010.0..10./s1
InChIKeyMTSPVILWFDDQST-HCGLHAMGSA-N
XLogP18.41
TPSA365.47 Ų
H-Bond Donors11
H-Bond Acceptors36
Rotatable Bonds37
Heavy Atoms195
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002802.16
LogP ≤ 518.41
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine?
The IUPAC name of 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine (CID 165031813) is 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine.
What is the SMILES notation for 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine?
The canonical SMILES for 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine is CC(C)(C)NC1CCOC1.CC(C)(C)NCC1CN(C(=O)C(F)(F)F)CCO1.CC(C)(C)NCC1CN(C2COC2)CCO1.CC(C)(C)NCCC1CCCOC1.CC(C)(C)NC[C@@H]1CN(C2COC2)CCO1.CC(C)(C)NC[C@H]1CN(C(=O)C(F)(F)F)CCO1.CC(C)(C)NC[C@H]1CN(C2COC2)CCO1.CC(C)(C)N[C@@H]1CCOC1.CC(C)(C)N[C@H]1CCOC1.CCN1CCO[C@@H](CCCCC(C)(C)C)C1.CCN1CCO[C@H](CCCCC(C)(C)C)C1.CN(C)CC(=O)N1CCC(CNC(C)(C)C)CC1.CN(C)CC(=O)N1CCCC(CNC(C)(C)C)C1.
What is the InChIKey of 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine?
The InChIKey is MTSPVILWFDDQST-HCGLHAMGSA-N. The full InChI is InChI=1S/2C14H29N3O.2C14H29NO.3C12H24N2O2.2C11H19F3N2O2.C11H23NO.3C8H17NO/c1-14(2,3)15-10-12-6-8-17(9-7-12)13(18)11-16(4)5;1-14(2,3)15-9-12-7-6-8-17(10-12)13(18)11-16(4)5;2*1-5-15-10-11-16-13(12-15)8-6-7-9-14(2,3)4;3*1-12(2,3)13-6-11-7-14(4-5-16-11)10-8-15-9-10;2*1-10(2,3)15-6-8-7-16(4-5-18-8)9(17)11(12,13)14;1-11(2,3)12-7-6-10-5-4-8-13-9-10;3*1-8(2,3)9-7-4-5-10-6-7/h2*12,15H,6-11H2,1-5H3;2*13H,5-12H2,1-4H3;3*10-11,13H,4-9H2,1-3H3;2*8,15H,4-7H2,1-3H3;10,12H,4-9H2,1-3H3;3*7,9H,4-6H2,1-3H3/t;;2*13-;2*11-;;8-;;;2*7-;/m..1010.0..10./s1.
What are the key properties of 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine?
1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine has a molecular weight of 2802.16 g/mol, XLogP of 18.41, 37 rotatable bonds, 11 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(2S)-2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[2-[(tert-butylamino)methyl]morpholin-4-yl]-2,2,2-trifluoroethanone;1-[3-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;1-[4-[(tert-butylamino)methyl]piperidin-1-yl]-2-(dimethylamino)ethanone;N-tert-butyloxolan-3-amine;(3R)-N-tert-butyloxolan-3-amine;(3S)-N-tert-butyloxolan-3-amine;(2R)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;(2S)-2-(5,5-dimethylhexyl)-4-ethylmorpholine;2-methyl-N-[2-(oxan-3-yl)ethyl]propan-2-amine;2-methyl-N-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[(2S)-4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine;2-methyl-N-[[4-(oxetan-3-yl)morpholin-2-yl]methyl]propan-2-amine is sourced from PubChem (CID 165031813), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).